Alzheimer’s and Parkinson’s Disease at AD/PD ’26
Nordic Bioscience´s neurology team has had 4 abstracts accepted at the The AD/PD™ Alzheimer’s Disease and Parkinson’s Disease Conference in 2026.
Abstract titles:
- Biomarker Profiling for the Diagnosis of PD (Meryem Benmarce, Signe Holm Nielsen, Kim Henriksen)
- Biomarkers Of Blood Brain Barrier Integrity Are Modulated In Neurological Disorders (Kim Henriksen, Nicholas Willumsen, Signe Holm Nielsen)
- The Serum Calprotectin Biomarker Is Upregulated In Patients With Parkinson’s Disease (Signe Holm Nielsen, Kim Henriksen)
- The Blood-based Biomarker Tau-c Is Related To Neurodegeneration, But Not Neuroinflammation (Signe Holm Nielsen, Kim Henriksen)
The abstracts cover the following topics:
- Modulation of blood-brain barrier integrity biomarkers in neurological disorders
- Upregulation of serum calprotectin biomarkers in patients with Parkinson’s Disease
- Elevation of type III and IV collagen fragments in the serum of treatment naïve multiple sclerosis patients
- Biomarker profiling for the diagnosis of Parkinson’s disease
